High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Julie Helms, Charles Tacquard, François Séverac, +15

Intensive Care Medicine

ThrombosisVenous ThrombosisCovid-19 PandemicCovid-19 EpidemiologySevere Sars-cov-2 Infection +5

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

J L Binet, Ariane Auquier, Guillaume Dighiero, +16

Cancer

Chronic Lymphocytic LeukemiaNew Prognostic ClassificationPrognosisPathologyCll Patients +21

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

Jean‐François Obadia, David Messika‐Zeitoun, Guillaume Leurent, +27

New England Journal of Medicine

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Naiyer A. Rizvi, Julien Mazières, David Planchard, +27

The Lancet Oncology

Checkmate 063Single-arm TrialMedicineImmunologyImmune Checkpoint Inhibitor +6

High versus Low Blood-Pressure Target in Patients with Septic Shock

Pierre Asfar, Ferhat Meziani, Jean‐François Hamel, +28

New England Journal of Medicine

Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic

Zahra Belhadjer, Mathilde Méot, Fanny Bajolle, +26

Circulation

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study

Olivier Rouvière, Philippe Puech, Raphaële Renard‐Penna, +47

The Lancet Oncology

UrologyMultiparametric MriMedical ImagingBiopsy-naive PatientsBenign Prostatic Hyperplasia +5

Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline

Marco Pennazio, Cristiano Spada, Rami Eliakim, +23

Endoscopy

Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

David Planchard, Benjamin Besse, Harry J.M. Groen, +13

The Lancet Oncology

Multicentre Phase 2MedicineMetronomic TherapyPathologyCancer Treatment +4

CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

Fabian Müller, Jule Taubmann, Laura Bucci, +25

New England Journal of Medicine